Citi upgrades PT for Australia's Sigma Healthcare on FY profit jump
** Analysts at Citi upgrade price target on Australia's
Sigma Healthcare SIG.AX to A$1.30/share from A$1.15/share
** Increases FY25-FY26 EBIT forecasts by 4-5% on higher FY
revenue and margins
** Brokerage maintains "neutral" rating on the
pharmaceutical distributor
** SIG posted FY net profit of A$4.50 mln ($2.98 mln), up
149% YTD
** Stock up 22.4% YTD, as of last close
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))